Bevacizumab enhances oxygen delivery by normalizing the tumor vasculature and reducing HIF-1α stabilization, which indirectly results in preserved epithelial junctions and the suppression of EMT-mediated invasion [124,125]. This evidence concerns the gene HIF1A and neoplasm.